The EPS projection of Tenet Healthcare Corporation (NYSE:THC) for period quarter closed 2016-12-31 is $0.55.
The EPS estimates given 30-days and 1 week ago were $0.55 and $0.55, correspondingly. This number 90 and 60 days before was $0.55 and $0.55 respectively. Yet, from last week, the change in EPS prediction is 0%.
For the quarter ended 2 mean estimate is $0.55 based on 10 EPS estimations. As on 2016-08-01 estimated EPS was $0.38 showing surprise of $-0.11, or -22.45%. Following the given predictions, the standard deviation is $0.06.
The upgrade count for EPS revisions was 0 a week earlier paralleled to negative revisions of 0. In last 60-days and 1- month, the upgrade in EPS reviews were 1 and 0 correspondingly, though for a quarter and 120-days ago, it was 3 and 3 in that sequence.
The negative reviews of EPS in the last 60-days and 1-month were 0 and 0 in that order. But, a quarter and 120-days ago, this numeral was 1 and 1 correspondingly.
EPS reviews downgrade and upgrade for last 18 days were 3 and 4, correspondingly.
Quarterly Sales Estimates
The mathematical mean of apparent yearly sales of Tenet Healthcare Corporation (NYSE:THC) is $5101.666 and the median is $5189. The estimate is stated by 3 analysts for the fiscal 2017.
The highest yearly projection is $5276 and lowest sales mark is $4840. This results a standard deviation of $230.747.
Almost 3 have reviewed sales target for better in the past week and 3 have downgraded forecasts. Subject to the stated estimates, the intended change in disclosed target from the past week is 0%.
Nearly 3 revised sales predictions for better over the past month and 3 have downgraded forecasts. It suggests an average deviation of -1.077% across given estimates.
Just about 3 have revised sales forecast up over the quarter and 3 have downgraded forecasts, hinting to a deviation of -2.271%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...